Published in AIDS Patient Care STDS on November 01, 2012
Trial of Collaborative Depression Care Management for HIV Patients (SLAM DUNC) | NCT01372605
Conformity of pediatric/adolescent HIV clinics to the patient-centered medical home care model. AIDS Patient Care STDS (2013) 0.94
Providers' attitudes towards treating depression and self-reported depression treatment practices in HIV outpatient care. AIDS Patient Care STDS (2013) 0.92
Exploring the medical home in Ryan White HIV care settings: a pilot study. J Assoc Nurses AIDS Care (2014) 0.90
The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS (2015) 0.89
Improvements in depression and changes in quality of life among HIV-infected adults. AIDS Care (2014) 0.88
Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon. AIDS Behav (2014) 0.86
Patient-centered care for people living with multimorbidity. Curr Opin HIV AIDS (2014) 0.82
Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon. PLoS One (2015) 0.80
Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences. J AIDS Clin Res (2014) 0.79
Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics. J Affect Disord (2015) 0.77
Comparative effectiveness of dual-action versus single-action antidepressants for the treatment of depression in people living with HIV/AIDS. J Affect Disord (2017) 0.77
Balancing Contamination and Referral Bias in a Randomized Clinical Trial: An Application of Pseudo-Cluster Randomization. Am J Epidemiol (2015) 0.76
Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care. J Acquir Immune Defic Syndr (2016) 0.75
Improving mental health among people living with HIV: a review of intervention trials in low- and middle-income countries. Glob Ment Health (Camb) (2015) 0.75
Mind the Gap: Gaps in Antidepressant Treatment, Treatment Adjustments, and Outcomes among Patients in Routine HIV Care in a Multisite U.S. Clinical Cohort. PLoS One (2017) 0.75
Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial. AIDS Behav (2016) 0.75
When "need plus supply" does not equal demand: challenges in uptake of depression treatment in HIV clinical care. Psychiatr Serv (2014) 0.75
Comparative effectiveness of dual vs single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression. AIDS (2017) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry (2001) 5.22
Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care (2004) 4.92
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS (1999) 4.39
Residual symptoms after partial remission: an important outcome in depression. Psychol Med (1995) 3.23
Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med (2005) 2.83
Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr (2005) 2.69
Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med (1999) 2.36
Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr (2008) 2.35
Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS (2006) 2.30
Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med (2003) 2.21
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry (1999) 1.84
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry (2004) 1.75
Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry (2002) 1.73
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. J Clin Psychiatry (2003) 1.56
Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord (2007) 1.56
Patient-centered care and preference-sensitive decision making. JAMA (2009) 1.44
Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Arch Gen Psychiatry (1997) 1.36
Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS (2005) 1.33
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D. J Gen Intern Med (2008) 1.28
Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. Am J Psychiatry (1994) 1.24
Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry (1994) 1.22
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. J Clin Psychopharmacol (2007) 1.09
Psychiatric disorder in HIV infection. Aust N Z J Psychiatry (1998) 1.04
Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDS (2010) 1.04
Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci (2008) 0.95
Race, outpatient mental health service use, and survival after an AIDS diagnosis in the highly active antiretroviral therapy era. AIDS Patient Care STDS (2010) 0.84
The Texas Medication Algorithm Project Patient and Family Education Program: a consumer-guided initiative. J Clin Psychiatry (2000) 0.81
Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol (2005) 8.67
Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 7.78
The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45
Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med (2009) 4.17
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis (2009) 3.91
Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med (2008) 2.65
Screening for and treatment of suicide risk relevant to primary care: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.36
Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med (2011) 2.31
Deployment and the use of mental health services among U.S. Army wives. N Engl J Med (2010) 2.21
Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings? Clin Infect Dis (2006) 2.07
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 2.02
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med (2005) 1.83
Mental health treatment to reduce HIV transmission risk behavior: a positive prevention model. AIDS Behav (2010) 1.67
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry (2007) 1.67
Deployment and mental health diagnoses among children of US Army personnel. Arch Pediatr Adolesc Med (2011) 1.66
Interventions to prevent post-traumatic stress disorder: a systematic review. Am J Prev Med (2013) 1.64
Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry (2013) 1.61
A comparison of the wellbeing of orphans and abandoned children ages 6-12 in institutional and community-based care settings in 5 less wealthy nations. PLoS One (2009) 1.56
Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care (2010) 1.55
HIV/AIDS in the Southern USA: a disproportionate epidemic. AIDS Care (2013) 1.45
STAR*D: revising conventional wisdom. CNS Drugs (2009) 1.41
Depression, sexually transmitted infection, and sexual risk behavior among young adults in the United States. Arch Pediatr Adolesc Med (2009) 1.41
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology (2007) 1.39
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry (2009) 1.38
A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med (2011) 1.38
Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men. AIDS (2013) 1.27
Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis. Drug Saf (2008) 1.20
Insomnia in patients with depression: a STAR*D report. CNS Spectr (2010) 1.18
Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study. Contemp Clin Trials (2012) 1.14
Health-related quality of life in depression: a STAR*D report. Ann Clin Psychiatry (2010) 1.13
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry (2011) 1.12
Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immune Defic Syndr (2005) 1.09
Diagnostic accuracy of Spanish language depression-screening instruments. Ann Fam Med (2009) 1.09
Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS (2012) 1.09
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord (2012) 1.08
Successful aging and the epidemiology of HIV. Clin Interv Aging (2011) 1.08
Prevalence and predictors of HIV-related stigma among institutional- and community-based caregivers of orphans and vulnerable children living in five less-wealthy countries. BMC Public Health (2010) 1.08
The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep (2012) 1.06
Ethnicity/race and outcome in the treatment of depression: results from STAR*D. Med Care (2007) 1.06
Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. Gen Hosp Psychiatry (2004) 1.01
The general and comparative efficacy and safety of duloxetine in major depressive disorder: a systematic review and meta-analysis. Drug Saf (2009) 1.00
Generalist care managers for the treatment of depressed medicaid patients in North Carolina: a pilot study. BMC Fam Pract (2007) 0.99
Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PLoS One (2012) 0.99
Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. Int Clin Psychopharmacol (2005) 0.97
Physical activity and depressive symptoms among pregnant women: the PIN3 study. Arch Womens Ment Health (2010) 0.95
Depressive symptoms among working women in rural North Carolina: a comparison of women in poultry processing and other low-wage jobs. Int J Law Psychiatry (2007) 0.93
Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. Depress Anxiety (2012) 0.92
The adverse effects of comorbid pain on depression outcomes in primary care patients: results from the ARTIST trial. Pain Med (2010) 0.92
A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States. AIDS Care (2011) 0.92
Providers' attitudes towards treating depression and self-reported depression treatment practices in HIV outpatient care. AIDS Patient Care STDS (2013) 0.92
Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort. J Clin Psychiatry (2007) 0.91
Guideline-concordant antidepressant use among patients with major depressive disorder. Gen Hosp Psychiatry (2010) 0.91
A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav (2013) 0.91
Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. Psychosomatics (2008) 0.90
Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. Int Clin Psychopharmacol (2008) 0.90
Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders. Dig Dis Sci (2009) 0.89
Practice-based interventions addressing concomitant depression and chronic medical conditions in the primary care setting: a systematic review and meta-analysis. J Prim Care Community Health (2013) 0.89
The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS (2015) 0.89
Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. Psychiatr Serv (2010) 0.89
Prescription refill records as a screening tool to identify antidepressant non-adherence. Pharmacoepidemiol Drug Saf (2010) 0.89
Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. Prim Care Companion J Clin Psychiatry (2007) 0.88
Improvements in depression and changes in quality of life among HIV-infected adults. AIDS Care (2014) 0.88
Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. Psychiatr Serv (2011) 0.88
Treatment use and costs among privately insured youths with diagnoses of bipolar disorder. Psychiatr Serv (2012) 0.87
Accuracy of standard measures of family planning service quality: findings from the simulated client method. Stud Fam Plann (2014) 0.86
Evaluation of the Menopause-Specific Quality of Life Questionnaire: a factor-analytic approach. Menopause (2012) 0.86
Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. J Am Pharm Assoc (2003) (2009) 0.86
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J Psychiatr Pract (2008) 0.86
Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon. AIDS Behav (2014) 0.86
Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Inj Prev (2012) 0.85
[Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru]. Rev Chilena Infectol (2013) 0.85
In-home mental health treatment for individuals with HIV. AIDS Patient Care STDS (2012) 0.85
Predicting fatigue and depression in HIV-positive gay men. Psychosomatics (2002) 0.84
Quality of Care and Contraceptive Use in Urban Kenya. Int Perspect Sex Reprod Health (2015) 0.84
Ranking antidepressants. Lancet (2009) 0.84
Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study. Psychiatr Serv (2010) 0.83
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. Am J Epidemiol (2011) 0.82
Relationship of clinical depression to periodontal treatment outcome. J Periodontol (2002) 0.82
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report. Int J Neuropsychopharmacol (2011) 0.81
Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Saf (2014) 0.81
Light therapy for preventing seasonal affective disorder. Cochrane Database Syst Rev (2015) 0.81
The association between antidepressant dosage titration and medication adherence among patients with depression. Depress Anxiety (2012) 0.80
Use of antipsychotic medications in pediatric and young adult populations: future research needs. J Psychiatr Pract (2015) 0.80
Depression and comorbid panic in primary care patients. J Affect Disord (2009) 0.80
Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose. Med Decis Making (2009) 0.80
Investigating differences in treatment effect estimates between propensity score matching and weighting: a demonstration using STAR*D trial data. Pharmacoepidemiol Drug Saf (2012) 0.80
Social network clustering and the spread of HIV/AIDS among persons who inject drugs in two cities in the Philippines. J Acquir Immune Defic Syndr (2017) 0.79
Second-generation antidepressants for seasonal affective disorder. Cochrane Database Syst Rev (2011) 0.79
Can shelter-based interventions improve treatment engagement in homeless individuals with psychiatric and/or substance misuse disorders?: a randomized controlled trial. Med Care (2005) 0.79
Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol (2013) 0.79
Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis. CNS Drugs (2014) 0.79
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. Depress Anxiety (2012) 0.79